DE602004028736D1 - Verbesserungen bei der virusproduktion - Google Patents

Verbesserungen bei der virusproduktion

Info

Publication number
DE602004028736D1
DE602004028736D1 DE602004028736T DE602004028736T DE602004028736D1 DE 602004028736 D1 DE602004028736 D1 DE 602004028736D1 DE 602004028736 T DE602004028736 T DE 602004028736T DE 602004028736 T DE602004028736 T DE 602004028736T DE 602004028736 D1 DE602004028736 D1 DE 602004028736D1
Authority
DE
Germany
Prior art keywords
virus production
virus
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004028736T
Other languages
English (en)
Inventor
Gregory V Williams
Kenneth Hughes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbix Biosystems Inc
Original Assignee
Microbix Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33545338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004028736(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microbix Biosystems Inc filed Critical Microbix Biosystems Inc
Publication of DE602004028736D1 publication Critical patent/DE602004028736D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004028736T 2003-06-20 2004-06-18 Verbesserungen bei der virusproduktion Expired - Lifetime DE602004028736D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47972303P 2003-06-20 2003-06-20
US54078204P 2004-01-30 2004-01-30
US57271804P 2004-05-20 2004-05-20
PCT/CA2004/000901 WO2004113518A1 (en) 2003-06-20 2004-06-18 Improvements in virus production

Publications (1)

Publication Number Publication Date
DE602004028736D1 true DE602004028736D1 (de) 2010-09-30

Family

ID=33545338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004028736T Expired - Lifetime DE602004028736D1 (de) 2003-06-20 2004-06-18 Verbesserungen bei der virusproduktion

Country Status (10)

Country Link
US (2) US7270990B2 (de)
EP (1) EP1636352B1 (de)
JP (1) JP4558652B2 (de)
AR (1) AR044843A1 (de)
AT (1) ATE478137T1 (de)
AU (1) AU2004249802B2 (de)
CA (1) CA2503774C (de)
DE (1) DE602004028736D1 (de)
MX (1) MXPA05005306A (de)
WO (1) WO2004113518A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2442822C2 (ru) * 2005-01-25 2012-02-20 Вайет Рисерч Айрлэнд Лимитед Вещества, защищающие клетки от рассечения при сборе микрофильтрацией
WO2008021493A2 (en) * 2006-08-18 2008-02-21 Huiru Wang A process for identification of molecular mimicry and the uses thereof
EP2318044B1 (de) * 2008-08-01 2015-12-02 Gamma Vaccines Pty Limited Influenza-impfstoffe
WO2010079081A1 (en) * 2009-01-07 2010-07-15 Glaxosmithkline Biologicals S.A. Methods for recovering a virus or a viral antigen produced by cell culture
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
WO2012100302A1 (en) 2011-01-27 2012-08-02 Gamma Vaccines Pty Limited Combination vaccines
EP3013947B1 (de) * 2013-06-28 2018-10-24 IntelliCyt Corporation Behandlung von biologischem material zur durchflusszytometriebeurteilung für viruspartikel
CN105505889A (zh) * 2015-12-24 2016-04-20 华南农业大学 一种禽流感病毒纯化的方法
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB660109A (en) * 1946-10-01 1951-10-31 American Cyanamid Co Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine
US3105012A (en) * 1961-10-19 1963-09-24 Parke Davis & Co Antigen products and means for producing the same
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
AU405949B1 (en) 1966-02-24 1970-09-18 The Australian National University Influenza virus sub-unit vaccine
GB1214135A (en) * 1967-02-21 1970-12-02 Wellcome Found Vaccines
US3627873A (en) * 1967-06-09 1971-12-14 Arden Wesley Moyer Influenza vaccine with reduced pyrogenicity
US3470067A (en) * 1967-09-19 1969-09-30 Pfizer & Co C Concentration and purification of viruses from particulate magnetic iron oxide-virus complexes
FR1604134A (de) * 1967-09-26 1971-07-12
US3547779A (en) * 1968-12-18 1970-12-15 Merck & Co Inc Process for producing purified concentrated influenza virus
US3870598A (en) * 1971-04-01 1975-03-11 Alexandra Konstantino Alexeeva Influenzal vaccine for peroral administration and a method of producing same
US4206287A (en) * 1972-07-21 1980-06-03 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines and their preparation
US3919044A (en) * 1973-03-28 1975-11-11 Armour Pharma Processes for concentrating and purifying viruses and viral antigens
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
US3874999A (en) * 1973-10-31 1975-04-01 American Cyanamid Co Process for the purification of virus vaccine
US4000257A (en) * 1975-12-22 1976-12-28 American Cyanamid Company Process for the purification of influenza virus vaccine
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4057626A (en) * 1976-10-08 1977-11-08 Richardson-Merrell Inc. Process for detoxifying influenza B virus
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
US4338296A (en) * 1979-10-16 1982-07-06 Smithkline-Rit Influenza virus and process of producing a vaccine therefrom
DE3014189A1 (de) * 1980-04-14 1981-10-15 Europäisches Laboratorium für Molekularbiologie (EMBL), 6900 Heidelberg Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren
US4327182A (en) * 1981-01-22 1982-04-27 Connaught Laboratories Incorporated Purification of influenza sub-unit vaccine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
US4783411A (en) * 1984-10-22 1988-11-08 Janis Gabliks Influenza-A virus vaccine from fish cell cultures
US4808518A (en) * 1985-02-11 1989-02-28 University Of Tennessee Research Corporation Recovery of cytomegalovirus antigen and use thereof in an assay
US4762939A (en) * 1987-09-30 1988-08-09 Union Carbide Corporation Process for trialkoxysilane/tetraalkoxysilane mixtures from silicon metal and alcohol
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
AU5000796A (en) 1996-01-05 1997-08-01 CESA, Clean Energy SA Process for the deactivation of hiv and other viruses
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
EP0848956A1 (de) * 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo Impfung gegen die Newcastle-Krankheit
GB9705740D0 (en) * 1997-03-20 1997-05-07 Medeva Europ Ltd A method of preservation
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
GB9716611D0 (en) * 1997-08-07 1997-10-08 Cantab Pharmaceuticals Res Ltd Virus preparations and methods
US6210683B1 (en) * 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
NZ518945A (en) 1997-10-09 2007-03-30 Wellstat Biologics Corp Treatment of neoplasms with viruses
US7780962B2 (en) * 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
KR100281676B1 (ko) 1997-11-29 2001-04-02 신동권 신규한독감생백신바이러스
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
EP0974660A1 (de) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
AT408615B (de) 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
EP1390046A4 (de) 1999-04-15 2005-04-20 Wellstat Biologics Corp Behandlung von neoplasmen mit viren
US20040052800A1 (en) 2000-08-07 2004-03-18 Bruce Carpick Stabilization of immunogens derived from paramyxoviruses
AU2002223560B2 (en) 2000-09-25 2006-06-29 Polymun Scientific Immunbiologische Forschung Gmbh Live influenza vaccine and method of manufacture
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
EP1361889A1 (de) 2001-02-23 2003-11-19 GlaxoSmithKline Biologicals S.A. Neue vakzine
WO2002087494A2 (en) 2001-04-27 2002-11-07 Glaxosmithkline Biologicals, Sa Novel vaccine
US7033813B2 (en) * 2001-09-05 2006-04-25 Trevor P Castor Inactivated vaccines for aids and other infectious diseases
AU2003229159B2 (en) 2002-04-30 2008-02-21 Oncolytics Biotech Inc. Improved viral purification methods

Also Published As

Publication number Publication date
CA2503774A1 (en) 2004-12-29
WO2004113518A1 (en) 2004-12-29
EP1636352B1 (de) 2010-08-18
US7270990B2 (en) 2007-09-18
US20050186223A1 (en) 2005-08-25
JP2006511240A (ja) 2006-04-06
AR044843A1 (es) 2005-10-05
AU2004249802B2 (en) 2007-06-28
CA2503774C (en) 2007-09-25
US20090035837A1 (en) 2009-02-05
ATE478137T1 (de) 2010-09-15
AU2004249802A1 (en) 2004-12-29
EP1636352A1 (de) 2006-03-22
MXPA05005306A (es) 2005-10-26
JP4558652B2 (ja) 2010-10-06

Similar Documents

Publication Publication Date Title
ATE363383T1 (de) Schlingenware
DE502004001683D1 (de) Kabelführung
AT502792A5 (de) Düsenanpressvorrichtung
DE502004007911D1 (de) Wischblatt
DE112004000620D2 (de) Struktoguss
DE502004000672D1 (de) Pigmentpreparationen
FR2862675B1 (fr) Defonceuse
DE502004001524D1 (de) Hydrolager
ATA662003A (de) Trink-mundstück
ATE478137T1 (de) Verbesserungen bei der virusproduktion
ATE446959T1 (de) Chromenonindole
DE502004001629D1 (de) Bremsenprüfstand
DE502004003122D1 (de) Hydrolager
DE502004002978D1 (de) N-biarylamide
DE502004000518D1 (de) Mitgängergabelhubwagen
DE502004006563D1 (de) Brieftaubenkonstatiersystem
DE10394329D2 (de) Mäanderstent
DE502004005162D1 (de) Leistungsregelvorricthung
DE10355350A8 (de) Elektromodul
ATE406350T1 (de) Prolinylarylacetamide
DE112004002227D2 (de) Nietverarbeitungsgerät
DE10329218B4 (de) Hotflue
DE502004002771D1 (de) Umlenkhebel
DE502004004175D1 (de) Verbrennungskraftmaschime
DE502004007251D1 (de) En 2-arylpropenalen